- RIUMA Principal
- Listar por autor
Listar por autor "Kazantseva, Liliya"
Mostrando ítems 1-4 de 4
-
Novel approaches for osteosarcoma treatment: drug combination, nanotechnology and cell therapy
Kazantseva, Liliya (UMA Editorial, 2023-03-03)Osteosarcoma is one of the most common malignant tumours of bone, primarily affecting children and adolescents. Although the implementation of chemotherapy and radiotherapy has substantially improved survival of patients ... -
Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
Kazantseva, Liliya; Becerra-Ratia, José; Santos-Ruiz, Leonor (Springer, 2021-08-24)Background Doxorubicin is the chemotherapeutic drug of choice in osteosarcoma treatment, but its cumulative administration causes dilated cardiomyopathy. Combination therapy represents a potential strategy to reduce the ... -
Secretory Profile of Adipose-Tissue-Derived Mesenchymal Stem Cells from Cats with Calicivirus-Positive Severe Chronic Gingivostomatitis
Villatoro, Antonio J.; Martín Astorga, María del Carmen; Alcoholado Cueto, Cristina; Kazantseva, Liliya; Cárdenas García, Casimiro; Fariñas Guerrero, Fernando; Becerra-Ratia, José; Visser, Rick[et al.] (IOAP-MPDI, 2022-05-25)The feline calicivirus (FCV) causes infections in cats all over the world and seems to be related to a broad variety of clinical presentations, such as feline chronic gingivostomatitis (FCGS), a severe oral pathology in ... -
Traditional Medicinal Plants as a Source of Inspiration for Osteosarcoma Therapy.
Kazantseva, Liliya; Becerra-Ratia, José; Santos-Ruiz, Leonor (MDPI, 2022-08-06)Osteosarcoma is one of the most common types of bone cancers among paediatric patients. Despite the advances made in surgery, chemo-, and radiotherapy, the mortality rate of metastatic osteosarcoma remains unchangeably ...